KANTARO - Trademark Details
Status: 819 - SU - Registration Review Complete
Serial Number
88922034
Word Mark
KANTARO
Status
819 - SU - Registration Review Complete
Status Date
2022-01-31
Filing Date
2020-05-18
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-05-18
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
PURATH, ANICKA S
Statements
Goods and Services
Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens and tissue; Assays, reagents, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agents, preparations, substances and diagnostic test kits primarily comprised of medical diagnostic reagents and assays, and also consisting of vessels, containers and implements being medical specimen collection and processing devices in the nature of tubes, swabs, bags, vials, laboratory bottles, cups, and laboratory pipettes for the collection and processing of blood, bodily fluids, biological and cellular samples and specimens and body tissue for performing serological and molecular tests, used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood, bodily fluids, biological and cellular samples and specimens and tissue for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Antibody diagnostic test for use in disease detection; Medical diagnostic test kits comprised of medical diagnostic assays, reagents, media, solutions in the nature of reagent solutions, substrate solutions, stop solutions, staining solutions, standard solutions and buffer solutions, buffers and diagnostic preparations for coronavirus, SARS-CoV-2 and COVID-19 diagnosis and monitoring
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-06-03
Primary Code
005
First Use Anywhere Date
2020-08-14
First Use In Commerce Date
2020-08-28
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Michelle A. Cooke
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-05-21 | NEW APPLICATION ENTERED IN TRAM |
2020-06-03 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-11-07 | ASSIGNED TO EXAMINER |
2020-11-08 | NON-FINAL ACTION WRITTEN |
2020-11-08 | NON-FINAL ACTION E-MAILED |
2020-11-08 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-02-26 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-02-26 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-03-01 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-04-01 | ASSIGNED TO EXAMINER |
2021-04-13 | EXAMINERS AMENDMENT -WRITTEN |
2021-04-13 | EXAMINERS AMENDMENT E-MAILED |
2021-04-13 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2021-04-13 | EXAMINER'S AMENDMENT ENTERED |
2021-04-13 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-04-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-05-18 | PUBLISHED FOR OPPOSITION |
2021-05-18 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-07-13 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2022-01-13 | TEAS STATEMENT OF USE RECEIVED |
2022-01-28 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2022-01-13 | USE AMENDMENT FILED |
2022-01-28 | STATEMENT OF USE PROCESSING COMPLETE |
2022-01-31 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2022-02-01 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |